Daily, in-home foot inspections
made easy

Empo Health is developing the Empo Footprint, an in-home imaging scale, and the Empo Remote Health Link, a digital health portal and remote patient monitoring service. Together, the solution will provide patients and clinicians with reliable visual data outside the clinic, seamlessly integrating into the standard of care with the help of Empo nurses.

Empo Footprint
Empo Remote Health Link

Visual assessment is fast and easy for the patient, and has been shown to yield fewer false positives than temperature-based methods

So patients get foot care when they need it.

Full-color imaging scale is designed for patient convenience and ease of use

The Empo Footprint enhances patient ease of use

The Empo Footprint simultaneously captures body weight and high-resolution, full-color images of the feet. It is designed to integrate seamlessly into a patient’s daily routine in place of a normal weight scale. Unlike other foot monitoring tools, the Empo Footprint offers a richer image that is more actionable than pressure- or temperature-based systems.

The Empo Remote Health Link portal streamlines image assessment

The Empo Footprint transfers data to the Empo Remote Health Link automatically through a built-in wireless connection. Image processing, comparison, and annotation features will make it easier for both clinicians and patients to monitor changes over time.

The Empo Remote Health Link service promotes clinical efficiency

Our solution is designed to fit into the clinical workflow and expand capacity for remote monitoring. Empo technicians will take care of device delivery and setup, and Empo nurses will assist with image review and patient engagement, fostering collaboration with clinicians for better diabetic foot care.

The Empo Footprint™ and the Empo Remote Health Link™ are intended to assist with visualizing the condition of the feet for skin changes and measure weight and are not diagnostic tools.
Empo’s products are undergoing clinical studies and will be registered with the FDA before public launch.

Want to learn more or partner with us?